Clinical trial
Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses
NCT00175643 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00175643 |
|---|---|
| Title | Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses |
| Official title | Open-Label Study to Assess Safety and Efficacy of Imiquimod 5% Cream Applied 3 Days Per Week in 1 or 2 Cycles for Treatment of Actinic Keratoses on the Head |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | Vancouver Coastal Health Research Institute 3M Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Actinic Keratoses |
| Intervention type | Drug |
| Interventions | imiquimod |
| Enrollment | 20 |
| Start date | Feb 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | May 9, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: